These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6014083)

  • 21. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
    HOLFELD H
    Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of LSD 25 and JB 318 on tests of visual and perceptual functions in man.
    OSTFELD AM
    Fed Proc; 1961 Dec; 20():876-84. PubMed ID: 14482599
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of lysergic acid diethylamide and bufotenine on performance of trained rats.
    MAHLER DJ; HUMOLLER FL
    Proc Soc Exp Biol Med; 1959; 102():697-701. PubMed ID: 14419947
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
    Trulson ME; Preussler DW; Trulson VM
    J Pharmacol Exp Ther; 1984 Jan; 228(1):94-102. PubMed ID: 6694110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross tolerance between LSD and psilocybin.
    ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
    Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
    [No Abstract]   [Full Text] [Related]  

  • 26. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.
    Lewis V; Bonniwell EM; Lanham JK; Ghaffari A; Sheshbaradaran H; Cao AB; Calkins MM; Bautista-Carro MA; Arsenault E; Telfer A; Taghavi-Abkuh FF; Malcolm NJ; El Sayegh F; Abizaid A; Schmid Y; Morton K; Halberstadt AL; Aguilar-Valles A; McCorvy JD
    Cell Rep; 2023 Mar; 42(3):112203. PubMed ID: 36884348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nature of opioid and LSD receptors: structural activity relationship implications.
    Martin WR
    NIDA Res Monogr; 1978; (22):60-9. PubMed ID: 30913
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the reactions induced by psilocybin and LSD-25 in man.
    ISBELL H
    Psychopharmacologia; 1959; 1():29-38. PubMed ID: 14405870
    [No Abstract]   [Full Text] [Related]  

  • 29. Hallucinogenic drugs and circadian rhythms.
    Davies JA; Ancill RJ; Redfern PH
    Prog Brain Res; 1972; 36():79-95. PubMed ID: 4644034
    [No Abstract]   [Full Text] [Related]  

  • 30. A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain.
    Nichols CD; Sanders-Bush E
    Neuropsychopharmacology; 2002 May; 26(5):634-42. PubMed ID: 11927188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
    Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
    J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychomimetic methylamphetamine derivatives.
    Knoll J; Vizi ES; Ecseri Z
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):442-51. PubMed ID: 5916746
    [No Abstract]   [Full Text] [Related]  

  • 33. Secale cornutum and the hallucinogenic drugs.
    Eisfelder HW
    J Am Inst Homeopath; 1967; 60(5):143-8. PubMed ID: 5630444
    [No Abstract]   [Full Text] [Related]  

  • 34. [The substance experience, a history of LSD].
    Beck F; Bonnet N
    Med Sci (Paris); 2013 Apr; 29(4):430-3. PubMed ID: 23621940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [LSD and hallucinogenic drugs].
    Rev Infirm Assist Soc; 1966 Dec; 16(10):962-3. PubMed ID: 4162401
    [No Abstract]   [Full Text] [Related]  

  • 36. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex.
    Reissig CJ; Rabin RA; Winter JC; Dlugos CA
    Eur J Pharmacol; 2008 Mar; 583(1):40-7. PubMed ID: 18262520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of 2,3-dihydro-lysergic acid diethylamide with LSD-25.
    Gorodetzky CW; Isbell H
    Psychopharmacologia; 1964 Sep; 6(3):229-33. PubMed ID: 5319153
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 40. Lysergic acid diethylamide (LSD) and JB 318: a comparison of two hallucinogens. II. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    Arch Gen Psychiatry; 1960 Aug; 3():176-87. PubMed ID: 14415047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.